Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Debt (2016 - 2025)

Haemonetics (HAE) has 16 years of Total Debt data on record, last reported at $1.2 billion in Q4 2025.

  • For Q4 2025, Total Debt changed 0.01% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, changed 0.01%, while the annual FY2025 figure was $1.2 billion, 51.62% up from the prior year.
  • Total Debt reached $1.2 billion in Q4 2025 per HAE's latest filing, roughly flat from $1.2 billion in the prior quarter.
  • Across five years, Total Debt topped out at $1.2 billion in Q3 2024 and bottomed at $707.6 million in Q2 2021.
  • Average Total Debt over 5 years is $936.1 million, with a median of $796.1 million recorded in 2021.
  • Peak YoY movement for Total Debt: skyrocketed 150.89% in 2022, then decreased 6.79% in 2023.
  • A 5-year view of Total Debt shows it stood at $780.8 million in 2021, then decreased by 1.79% to $766.8 million in 2022, then increased by 13.54% to $870.6 million in 2023, then skyrocketed by 40.69% to $1.2 billion in 2024, then fell by 0.01% to $1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.